View |
|
DR-XY29141
|
Phenylephrine Hydrochloride + Brompheniramine Maleate
|
REMEDRIL
|
5 mg/2 mg per 5 mL
|
Syrup
|
Decongestant / Antihistamine
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
18 October 2023
|
11 December 2028
|
View |
|
DR-XY29143
|
Phenylephrine Hydrochloride + Brompheniramine Maleate
|
REMEDRIL
|
1 mg/0.8 mg per mL
|
Syrup (Oral Drops)
|
Decongestant / Antihistamine
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
27 October 2023
|
11 December 2028
|
View |
|
DR-XY29144
|
Sodium Chloride
|
Snif
|
2.3 %
|
Spray Solution
|
-
|
Hizon Laboratories, Inc.
|
Philippines
|
Automatic Renewal (Reconstruction)
|
27 May 2023
|
12 November 2028
|
View |
|
DR-XY29146
|
Co-Amoxiclav
|
Sullivan
|
156.25mg / 5mL
|
Powder For Suspension
|
Antibacterial (Penicillin)
|
Lloyd Laboratories,Inc.
|
Philippines
|
Automatic Renewal
|
21 July 2023
|
11 November 2028
|
View |
|
DR-XY29153
|
Acetyl-L-Carnitine (as hydrochloride)
|
Levocetile
|
500 mg
|
Film-Coated Tablet
|
Nootropic
|
Korea United Pharm. Inc.
|
Korea
|
Initial (from Monitored Release)
|
30 May 2022
|
13 November 2024
|
View |
|
DR-XY29161
|
Cefaclor (as monohydrate)
|
Ephron
|
500 mg
|
Capsule
|
Antibacterials
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
10 June 2023
|
15 November 2028
|
View |
|
DR-XY29163
|
Omeprazole (as sodium)
|
Ulsek
|
40mg
|
Lyophilized Powder For Injection (I.V.)
|
Proton Pump Inhibitor
|
Standard Chemical and Pharmaceutical Co., Ltd.
|
Taiwan
|
Renewal
|
07 November 2023
|
18 November 2028
|
View |
|
DR-XY29183
|
Water-Soluble Vaitamin: Thiamine Mononitrate 3.1mg (corresponding to Vit B1, 2.5mg), Riboflavin Sodium Phosphate 4.9mg (corresponding to Vit B2, 3.6mg), Nicotinamide 40mg, Pyridoxine Hydrochloride 4.9mg (corresponding to Vit B6 4mg), Cyanocobalamin 5mcg, Sodium Pantothenate 16.5mg (corresponding to Pantothenic Acid, 15mg), Sodium Ascorbate 113mg (corresponding to Vit C, 100mg), Biotin 60mcg, Folic Acid 400mcg
|
Soluvit N
|
See Generic Name
|
Powder for IV Infusion
|
Parenteral Nutrition
|
Sino-Swed Pharmaceutical Corp. Ltd.
|
Sweden
|
Automatic Renewal
|
28 December 2021
|
22 March 2027
|
View |
|
DR-XY29184
|
Hydroxyethyl Starch 130/0.4 + Sodium Chloride
|
Voluven
|
6% / 0.9%
|
Solution For Intravenous Infusion
|
Plasma Expanders/Substitutes
|
Fresenius Kabi Deutschland GmbH
|
Germany
|
Renewal
|
15 November 2023
|
01 December 2028
|
View |
|
DR-XY29187
|
Sodium Chloride
|
Muconase
|
0.0065
|
Solution For Nasal Spray
|
-
|
Hizon Laboratories, Inc.
|
Philippines
|
-
|
22 February 2021
|
28 November 2025
|
View |
|
DR-XY29193
|
Amikacin (as sulfate)
|
Cinmik
|
250 mg/ mL (500 mg/ 2 mL)
|
Solution for Injection (IM/IV)
|
-
|
Karnataka Antibiotics and Pharamceuticla Ltd.
|
India
|
-
|
28 September 2021
|
27 November 2025
|
View |
|
DR-XY29194
|
Amikacin (as Sulfate)
|
Cinmik
|
50 mg/ mL (100 mg/ 2 mL)
|
Solution for Injection (I.M./I.V.)
|
-
|
Karnataka Antibiotics and Pharamceuticla Ltd.
|
India
|
-
|
28 September 2021
|
27 November 2025
|
View |
|
DR-XY29195
|
Phenylpropanolamine Hydrochloride + Brompheniramine Maleate
|
Nazaclir
|
6.25 mg/2 mg per mL
|
Syrup (Oral Drops)
|
Nasal Decongestant/ Antihistamine
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
01 August 2023
|
27 November 2028
|
View |
|
DR-XY29196
|
Phenylephrine Hydrochloride + Chlorphenamine Maleate
|
Bronchofen
|
1.0mg/800mcg
|
Syrup
|
Sympathomimetics used as decongestants
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
19 December 2023
|
27 November 2028
|
View |
|
DR-XY29222
|
Lacipidine
|
Lacipil
|
6 mg
|
Tablet
|
Selective Calcium Channel Blockers with Mainly Vascular Effects (Dihydropyridine derivative)
|
Glaxo Wellcome, S.A.
|
Spain
|
Renewal
|
30 December 2023
|
04 December 2028
|
View |
|
DR-XY29233
|
Remeron-Soltab
|
Mirtazapine
|
15 mg
|
Orodispersible Tablet
|
-
|
Anesta LLC
|
U.S.A.
|
-
|
21 January 2020
|
10 February 2025
|
View |
|
DR-XY29234
|
Teriparatide
|
Forteo
|
250 mcg/mL
|
Solution For Injection
|
Anti-Osteoporosis
|
Lilly France (Fegersheim)
|
France
|
Renewal
|
02 May 2022
|
09 December 2028
|
View |
|
DR-XY29235
|
Remeron-Soltab
|
Mirtazapine
|
45 mg
|
Orodispersible Tablet
|
-
|
Anesta LLC
|
U.S.A.
|
-
|
21 January 2020
|
17 January 2025
|
View |
|
DR-XY29236
|
Remeron-Soltab
|
Mirtazapine
|
30 mg
|
Orodispersible Tablet
|
-
|
Anesta LLC
|
U.S.A.
|
-
|
21 January 2020
|
17 January 2025
|
View |
|
DR-XY29245
|
Salbutamol (As Sulfate)
|
Ventar
|
1mg/mL
|
Nebulizing Solution For Inhalation
|
BRONCHODILATOR
|
Hizon Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
12 July 2023
|
11 December 2028
|